Search Results - "Kier, M G G"

Testosterone deficiency in testicular cancer survivors – a systematic review and meta‐analysis by Bandak, M., Jørgensen, N., Juul, A., Vogelius, I. R., Lauritsen, J., Kier, M. G., Mortensen, M. S., Glovinski, P., Daugaard, G.

“…Summary Results concerning treatment of Testicular Germ Cell Cancer (TGCC) and subsequent risk of testosterone deficiency are conflicting. To systematically…”
Get full text

Renal impairment and late toxicity in germ-cell cancer survivors by Lauritsen, J., Mortensen, M.S., Kier, M.G.G., Christensen, I.J., Agerbaek, M., Gupta, R., Daugaard, G.

“…Treatment with bleomycin–etoposide–cisplatin (BEP) impairs renal function and increases the risk of late cardiovascular disease (CVD) and death. We…”
Get full text

Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study by Kier, M G G, Lauritsen, J, Almstrup, K, Mortensen, M S, Toft, B G, Rajpert-De Meyts, E, Skakkebaek, N E, Rørth, M, von der Maase, H, Agerbaek, M, Holm, N V, Andersen, K K, Dalton, S O, Johansen, C, Daugaard, G

“…Screening programmes for contralateral carcinoma in situ (CIS) testis in patients with unilateral germ-cell cancer (GCC) have never been evaluated. We…”
Get full text

Reproductive hormones and metabolic syndrome in 24 testicular cancer survivors and their biological brothers by Bandak, M., Jørgensen, N., Juul, A., Lauritsen, J., Kier, M. G. G., Mortensen, M. S., Oturai, P. S., Mortensen, J., Hojman, P., Helge, J. W., Daugaard, G.

“…Summary Testicular cancer survivors have impaired gonadal function and increased risk of metabolic syndrome when compared to healthy controls. However, because…”
Get full text

Relapse and Mortality Risk of Stage I Testicular Cancer by Florvall, Cecilia, Frederiksen, Peder, Lauritsen, Jakob, Bandak, Mikkel, Kier, M Gry G, Mortensen, Mette S, Kreiberg, Michael, Daugaard, Gedske

“…- To assess the medical insurance risk for patients with stage I testicular cancer (TC), by calculating the overall mortality risk with and without relapse,…”
Get more information

Renal impairment and late toxicity in germ-cell cancer survivors by Lauritsen, J, Mortensen, M S, Kier, M G G, Christensen, I J, Agerbaek, M, Gupta, R, Daugaard, G

“…Treatment with bleomycin-etoposide-cisplatin (BEP) impairs renal function and increases the risk of late cardiovascular disease (CVD) and death. We…”
Get full text